C
Cardiol Therapeutics Inc. (CRDL)
NCM – Real vaqt narxi. Valyuta: USD
1.35
+0.01 (1.12%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.35
+0.01 (1.12%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Cardiol Therapeutics Inc., klinik bosqichdagi hayot fanlari kompaniyasi, yurak kasalliklarini davolash uchun anti-fibrotik va yallig'lanishga qarshi dorilarni ishlab chiqishga qaratilgan. Uning yetakchi mahsulot nomzodi CardiolRx bo'lib, u o'tkir miokarditda CardiolRxning samaradorligi va xavfsizligini, shuningdek, takroriy perikarditni davolashni baholash uchun III bosqichdagi ko'p millatli, randomizatsiyalangan, ikki tomonlama ko'r va platsebo-kontroll ostida bo'lgan tadqiqotda. Kompaniya, shuningdek, yurak etishmovchiligini davolash uchun kannabidiolning yangi teri ostiga yuboriladigan dori shakli bo'lgan CRD-38ni ishlab chiqmoqda. Cardiol Therapeutics Inc. 2017 yilda ro'yxatga olingan va uning shtab-kvartirasi Kanadaning Oakvill shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Andrew Warwick Hamer M.D. | Chief Medical Officer and Head of Research & Development |
| Mr. Bernard Lim B.Sc. | Chief Operating Officer |
| Mr. Christopher J. Waddick C.A., C.M.A., CPA, MBA | CFO, Corporate Secretary & Director |
| Mr. David G. Elsley MBA | President, CEO & Director |
| Mr. John A. Geddes BSCPT, MBA | Vice President of Corporate Development |
| Trevor Burns | Investor Relations |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 6-K | cardiol6k.htm |
| 2026-04-28 | 6-K | cardiol6k.htm |
| 2026-04-14 | 6-K | form6k.htm |
| 2026-04-10 | 6-K | tm2611243d1_6k.htm |
| 2026-04-01 | 6-K | form6k.htm |
| 2026-03-31 | 40-F | crdl-20251231x40f.htm |
| 2026-02-25 | 6-K | form6k.htm |
| 2026-02-10 | 6-K | form6k.htm |
| 2026-02-02 | 6-K | tm264808d1_6k.htm |
| 2026-01-26 | 6-K | form6k.htm |